Nextech Invest is a venture capital and private equity firm specializing in early, mid stage and late stage, and emerging growth.
Nextech Invest is a venture capital and private equity firm specializing in early, mid stage and late stage, and emerging growth investments. The firm also invests in incorporation, spin-outs, reverse-take-over, and PIPE transactions. It only considers investments where evidence in preclinical animal models that a drug is efficacious is available or a device prototype fulfills the requirements. The firm seeks to invest in the field of information technology, biotechnology, healthcare with a focus on oncology companies developing cancer drugs and diagnostics. It prefers to invest in life science and enabling technologies with a focus on interdisciplinary technical and scientific projects, therapies, diagnostics, medical technologies, and services. The firm seeks to invest in companies based in Africa, Middle East, Asia, North America, Europe including Switzerland, Germany, and neighboring regions. It also considers co-investments in rest of Europe. The firm seeks to invest between CHF 1 million ($0.93 million) and CHF 5 million ($4.7 million) per financing round. It seeks a Board position in the portfolio companies. The firm seeks to exit its investments within three years via trade sale. Nextech Invest Ltd. was founded in 1998 and is based in Zurich, Switzerland.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 14, 2022
Alpha9 Theranostics
|
Series B | $75M | Biotechnology | Yes |
Jan 7, 2021
Scorpion Therapeutics
|
Series B | $162M | Biotechnology | — |
Oct 6, 2020
A2 Biotherapeutics
|
Series B | $71.50M | Biotechnology | — |
Dec 5, 2019
Black Diamond Therapeutics
|
Series C | $85M | Biotechnology | — |
Nov 5, 2019
A2 Biotherapeutics
|
Series A | $57M | Biotechnology | — |